Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study.

Retroviral gene delivery systems for RNA polymerase II (RNA pol II)-based promoters have been developed and are widely used in gene transfer studies. In contrast, gene delivery systems with RNA pol III-based expression cassettes have not been studied comprehensively, although therapeutic applications (e.g., ribozymes, antisense, triplex RNA and RNA decoys) have been proposed. In this report, we describe retroviral vectors designed to optimize expression of short chimeric RNAs transcribed from a number of RNA pol III promoters. Our results show that all analysed RNA pol III expression cassettes (tRNA, U6, Ad VA1), regardless of orientation, do not transcribe efficiently when located between the retroviral long terminal repeats (LTRs). In contrast, high steady-state expression levels can be achieved by inserting the RNA pol III expression cassette into the U3 region of the LTR (double-copy design). Compared to human tRNA gene promoters (tRNA(Met), tRNA(Val)), the human small nuclear RNA U6 gene (U6) and the adenovirus virus-associated RNA 1 (Ad VA1) gene promoters yielded higher expression levels. The majority of the chimeric U6-derived transcripts were detected in the nuclear RNA fraction, and the VA1 and tRNA-driven transcripts were predominantly detected in the cytoplasmic compartments. This report is the first comparative study of RNA pol III-driven promoters expressing short chimeric transcripts leading to an optimized retroviral-vector design.

[1]  S. Altman,et al.  RNA enzyme-directed gene therapy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  O. Yamada,et al.  A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  W. Folk,et al.  Unraveling the complexities of transcription by RNA polymerase III. , 1990, Trends in biochemical sciences.

[4]  P. Molloy,et al.  Inhibition of SV40 replicon function by engineered antisense RNA transcribed by RNA polymerase III. , 1987, The EMBO journal.

[5]  Eli Gilboa,et al.  Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication , 1990, Cell.

[6]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[7]  J. Ojwang,et al.  Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Lee,et al.  Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. , 1992, The New biologist.

[9]  Armentano,et al.  Effect of internal viral sequences on the utility of retroviral vectors , 1987, Journal of virology.

[10]  M. Capecchi,et al.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.

[11]  M. Pawlita,et al.  Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA , 1991, Journal of virology.

[12]  T. Lee,et al.  Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication , 1990, Molecular and cellular biology.